Priser
Platform
Blog
Om os
Download
H9O1
HumanOptics
Xetra
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HUMANOPTICS MED ENDAVU: Køb HumanOptics ($H9O1) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i HumanOptics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerH9O1

Om

Nky Medical Holdings Ltd. is a prominent healthcare company specializing in the development, manufacture, and distribution of medical devices and related products. Its primary function is to provide innovative solutions that enhance healthcare diagnostics and therapeutic capabilities. The company's product portfolio includes wound care products, surgical instruments, and medical consumables that are essential in various clinical and hospital environments.

Notably, Nky Medical Holdings Ltd. has a notable impact on the healthcare and medical sectors, particularly in regions with increasing demand for modern medical technology. The company's products play a pivotal role in improving healthcare outcomes by ensuring efficiency and accuracy in medical procedures.

In the financial market, Nky Medical Holdings Ltd. is regarded as a significant player in the healthcare sector, contributing to advancements in medical technology and expanding access to essential healthcare tools. Its focus on regulatory compliance and technological innovation positions it as a key entity in the development and sustainability of global healthcare infrastructure.

Udbytter

0,01CNH
'21
0,32CNH
'22
0,32CNH
'23
1CNH
'24
0,25CNH
'25
0,17CNH
'26
Ex-udbytte-dato23. jun. 2026
Udbytteafkast1,26%